Molecular therapy for genetic muscle diseases--status 1999

Clin Genet. 1999 Jan;55(1):1-8. doi: 10.1034/j.1399-0004.1999.550101.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenoviridae
  • Animals
  • Cytoskeletal Proteins / deficiency
  • Cytoskeletal Proteins / metabolism
  • Cytoskeleton / metabolism
  • DNA / administration & dosage
  • Dystroglycans
  • Dystrophin / deficiency
  • Genetic Therapy*
  • Genetic Vectors
  • Humans
  • Membrane Glycoproteins / deficiency
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Inbred mdx
  • Muscle, Skeletal / metabolism
  • Muscles / anatomy & histology
  • Muscular Diseases / genetics*
  • Muscular Diseases / therapy*
  • Phosphorylases / deficiency
  • Sarcoglycans
  • Tibia / anatomy & histology
  • Up-Regulation
  • Utrophin

Substances

  • Cytoskeletal Proteins
  • DAG1 protein, human
  • Dystrophin
  • Membrane Glycoproteins
  • Membrane Proteins
  • Sarcoglycans
  • Utrn protein, mouse
  • Utrophin
  • Dystroglycans
  • DNA
  • Phosphorylases